The table below shows Cardiff Oncology, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$12.29M
-$12.79M
-$7.74M
-$8.66M
-$10.25M
-$5.88M
Capital expenditure
-
-
$80.00K
$8.00K
$171.00K
$0.00
Investing cash flow
$3.26M
-$14.58M
$4.64M
$7.33M
$18.36M
-$111.70M
Dividends paid
-
-
-
-
CRDF operating cash flow (10-K history)
Cardiff Oncology, Inc. reported operating cash flow of -$37.92M for fiscal year 2025. That is down 0.6% from -$37.69M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow declined from -$13.20M (FY 2018) to -$37.92M. Figures come from the company's audited annual reports as filed with the SEC.